Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer's disease
and related human tauopathies. There is a growing body of evidence indicating that …

Malaria, caused by Plasmodium species, remains a major global health concern, causing
millions of deaths annually. While the introduction of the RTS, S vaccine has shown promise …

Extensive control efforts have significantly reduced malaria cases and deaths over the past
two decades, but in recent years, coupled with the COVID-19 pandemic, success has …

Background BK-SE36 is blood-stage malaria vaccine candidate that is undergoing clinical
trials. Here, the safety and immunogenicity of BK-SE36 with a novel adjuvant, CpG-ODN …

Plasmodium falciparum malaria is a disease causing high morbidity and mortality rates
worldwide, mainly in sub-Saharan Africa. Candidates have been identified for vaccines …

Much of the gain in malaria control, in terms of regional achievements in restricting
geographical spread and reducing malaria cases and deaths, can be attributed to large …

Background: Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the
characteristics of this devastating disorder include the progressive and disabling deficits in …

Considerable progress has been made in malaria control in the last two decades, but
progress has stalled in the last few years. New tools are needed to achieve public health …

Background Plasmodium knowlesi is the most common cause of malaria in Malaysian
Borneo, with reporting limited to clinical cases presenting to health facilities and scarce data …

Serine repeat antigen (SERA) is conserved among species of the genus Plasmodium. Sera
genes form a multigene family and are generally tandemly clustered on a single …